<p>Competition prioritizes human evidence and clinical readiness over early promise with nominations for 2026 program closing shortly. Longevity medicine is rarely short of a headline. New biomarkers, sharper diagnostics, ever more elegant interventions – the science keeps arriving, and it keeps being </p>